Synopsis of recent research by authors named "Hobyung Chung"
- Hobyung Chung's research primarily focuses on liver-related conditions, particularly chronic hepatitis C, autoimmune hepatitis, and hepatocellular carcinoma (HCC), investigating their pathophysiology and treatment responses to various therapies including direct-acting antivirals (DAAs) and lenvatinib.
- Recent studies highlight the potential adverse effects of treatments, such as autoimmune hepatitis and primary sclerosing cholangitis following DAA use, and the risk factors for proteinuria in HCC patients receiving lenvatinib, indicating a significant need for careful patient management.
- Chung also explores the diagnostic utility of imaging techniques, including contrast-enhanced ultrasound and MRI, in assessing liver tumors, striving to improve early detection and treatment efficacy for liver pathologies.